About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Conformable GORE TAG Thoracic Endoprosthesis to be Launched in US

by Kathy Jones on January 25, 2012 at 12:02 AM
Font : A-A+

 Conformable GORE TAG Thoracic Endoprosthesis to be Launched in US

Delaware-based W L Gore & Associates announced that it will be introducing its Conformable GORE TAG Thoracic Endoprosthesis in the United States after it received approval from the Food and Drug Administration.

The company revealed that its device is the only thoracic endoprosthesis approved by the FDA for treating young trauma patients who have isolated lesions of the thoracic aorta. The company added that the device is easy to use and accommodates "tapered anatomy and resisting compression."

Advertisement

Stating that the device will provide conformability with every patient, David Abeyta, Gore Aortic Business Leader said, "We are proud to deliver to endovascular specialists and their patients the first FDA approved minimally invasive treatment option for treating traumatic aortic transaction."


Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Lung Transplantation
Baldness can be Cured and Prevented: let us see How!
Drinking Beer or Wine Every Day Could Cause Age-related Diseases
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Thoracic Outlet Syndrome 

Most Popular on Medindia

Blood - Sugar Chart Indian Medical Journals Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine) Loram (2 mg) (Lorazepam) Blood Pressure Calculator Find a Hospital Vent Forte (Theophylline) Color Blindness Calculator Blood Donation - Recipients
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use